Taiwan · Delayed Price · Currency is TWD Li Kang Biomedical Statistics
Total Valuation
TPEX:6242 has a market cap or net worth of TWD 1.08 billion. The enterprise value is 1.03 billion.
| Market Cap | 1.08B |
| Enterprise Value | 1.03B |
Important Dates
The last earnings date was Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Jun 16, 2026 |
Share Statistics
TPEX:6242 has 31.81 million shares outstanding. The number of shares has increased by 0.51% in one year.
| Current Share Class | 31.81M |
| Shares Outstanding | 31.81M |
| Shares Change (YoY) | +0.51% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 3.81% |
| Owned by Institutions (%) | n/a |
| Float | 12.61M |
Valuation Ratios
The trailing PE ratio is 14.28.
| PE Ratio | 14.28 |
| Forward PE | n/a |
| PS Ratio | 1.89 |
| PB Ratio | 1.28 |
| P/TBV Ratio | 1.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 14.17 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 13.48 |
| EV / Sales | 1.80 |
| EV / EBITDA | 10.92 |
| EV / EBIT | 11.81 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.04 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.34 |
| Debt / FCF | -0.71 |
| Interest Coverage | 254.94 |
Financial Efficiency
Return on equity (ROE) is 9.12% and return on invested capital (ROIC) is 8.81%.
| Return on Equity (ROE) | 9.12% |
| Return on Assets (ROA) | 4.84% |
| Return on Invested Capital (ROIC) | 8.81% |
| Return on Capital Employed (ROCE) | 9.72% |
| Weighted Average Cost of Capital (WACC) | 3.36% |
| Revenue Per Employee | 4.70M |
| Profits Per Employee | 626,148 |
| Employee Count | 122 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 3.62 |
Taxes
In the past 12 months, TPEX:6242 has paid 17.16 million in taxes.
| Income Tax | 17.16M |
| Effective Tax Rate | 18.34% |
Stock Price Statistics
The stock price has decreased by -19.91% in the last 52 weeks. The beta is -0.09, so TPEX:6242's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | -19.91% |
| 50-Day Moving Average | 36.18 |
| 200-Day Moving Average | 38.09 |
| Relative Strength Index (RSI) | 32.45 |
| Average Volume (20 Days) | 7,763 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6242 had revenue of TWD 573.36 million and earned 76.39 million in profits. Earnings per share was 2.38.
| Revenue | 573.36M |
| Gross Profit | 385.44M |
| Operating Income | 87.19M |
| Pretax Income | 93.55M |
| Net Income | 76.39M |
| EBITDA | 94.30M |
| EBIT | 87.19M |
| Earnings Per Share (EPS) | 2.38 |
Balance Sheet
The company has 178.22 million in cash and 126.56 million in debt, with a net cash position of 51.66 million or 1.62 per share.
| Cash & Cash Equivalents | 178.22M |
| Total Debt | 126.56M |
| Net Cash | 51.66M |
| Net Cash Per Share | 1.62 |
| Equity (Book Value) | 842.86M |
| Book Value Per Share | 26.40 |
| Working Capital | 10.43M |
Cash Flow
In the last 12 months, operating cash flow was 76.31 million and capital expenditures -253.74 million, giving a free cash flow of -177.43 million.
| Operating Cash Flow | 76.31M |
| Capital Expenditures | -253.74M |
| Depreciation & Amortization | 7.11M |
| Net Borrowing | 68.02M |
| Free Cash Flow | -177.43M |
| FCF Per Share | -5.58 |
Margins
Gross margin is 67.22%, with operating and profit margins of 15.21% and 13.32%.
| Gross Margin | 67.22% |
| Operating Margin | 15.21% |
| Pretax Margin | 16.32% |
| Profit Margin | 13.32% |
| EBITDA Margin | 16.45% |
| EBIT Margin | 15.21% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 5.88%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 5.88% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 83.27% |
| Buyback Yield | -0.51% |
| Shareholder Yield | 5.37% |
| Earnings Yield | 7.06% |
| FCF Yield | -16.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 30, 2023. It was a forward split with a ratio of 1.15.
| Last Split Date | Jun 30, 2023 |
| Split Type | Forward |
| Split Ratio | 1.15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |